Showing results (1801-1810 of 1,912) with videos related to
Sort By:
Pageof 192
American Journal of Ophthalmology|August 17, 2025
Sleep Disturbance as a Risk Factor for Retinal Neurodegeneration and Subsequent GlaucomaMasahiro Akada, Yuta Nakanishi, Midori Ideyama, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 3, 2023
Biodegradable or durable polymer drug-eluting stents in patients with coronary artery disease: ten-year outcomes of the randomised NEXT TrialMasahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto, et al.International Journal of Cardiology|March 16, 2015
Relative and absolute risks of all-cause and cause-specific deaths attributable to atrial fibrillation in middle-aged and elderly community dwellersMasaki Ohsawa, Tomonori Okamura, Kuniaki Ogasawara, et al.Medrxiv : the Preprint Server for Health Sciences|July 10, 2026
Incidence trends of nontuberculous mycobacterial pulmonary infections in Australia, Cambodia, Japan, Thailand, and the United StatesAtha R Pradana, Melinda M Ashcroft, Pichanee Watthanasiri, et al.Annals of the American Thoracic Society|April 9, 2021
Clinical Features and Prognosis of Nontuberculous Mycobacterial Pleuritis: A Multicenter Retrospective StudyKazuma Yagi, Akihiro Ito, Keiji Fujiwara, et al.JMIR Research Protocols|January 30, 2023
An Exploratory Trial of EPI-589 in Amyotrophic Lateral Sclerosis (EPIC-ALS): Protocol for a Multicenter, Open-Labeled, 24-Week, Single-Group StudyShotaro Haji, Koji Fujita, Ryosuke Oki, et al.JACC. Cardiovascular Interventions|April 6, 2019
7-Year Outcomes of a Randomized Trial Comparing the First-Generation Sirolimus-Eluting Stent Versus the New-Generation Everolimus-Eluting Stent: The RESET TrialHiroki Shiomi, Ken Kozuma, Takeshi Morimoto, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 21, 2025
LC16m8 for Pre-exposure Prophylaxis against Mpox in a High-Risk Population: An Open-Label Randomized TrialNobumasa Okumura, Eriko Morino, Hidetoshi Nomoto, et al.Journal of Cardiovascular Computed Tomography|February 10, 2018
Incidence and predictors of lesion-specific ischemia by FFRCT: Learnings from the international ADVANCE registryHironori Kitabata, Jonathon Leipsic, Manesh R Patel, et al.Neurology|May 26, 2026
Comparative Study of Sporadic and Immune Checkpoint Inhibitor-Related Forms of Myasthenia Gravis-Myositis Overlap SyndromeAntonio Lauletta, Elena Rossini, Francesca Beretta, et al.Pageof 192